Allergan USA, Inc. v. Imprimis Pharmaceuticals, Inc.
Plaintiff / Appellant: ALLERGAN USA, INC.
Defendant / Appellee: IMPRIMIS PHARMACEUTICALS, INC.
Case Number: 19-55756
Filed: July 1, 2019
Court: U.S. Court of Appeals, Ninth Circuit
Nature of Suit: Other
Docket Report

This docket was last retrieved on August 16, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 16, 2019 Filing 8 Filed (ECF) Appellant Allergan USA, Inc. response to Court Order dated 07/10/2019. Date of service: 08/16/2019 [11400368] [19-55756]--[COURT UPDATE: Updated docket text to reflect correct ECF filing type. 08/17/2019 by SLM] (Akrotirianakis, Joseph) [Entered: 08/16/2019 02:19 PM]
July 17, 2019 Filing 7 Terminated Philip K Lem for Imprimis Pharmaceuticals, Inc. in 19-55756 [11366609] (RR) [Entered: 07/17/2019 01:15 PM]
July 17, 2019 Filing 6 Filed (ECF) Notice of withdrawal of counsel. Filed by Attorney Mr. Philip K Lem, Esquire for Appellee Imprimis Pharmaceuticals, Inc.. Party proceeding without counsel: No. Date of service: 07/17/2019. [11366460] [19-55756] (Rasmussen, Daniel) [Entered: 07/17/2019 11:53 AM]
July 11, 2019 Filing 5 MEDIATION ORDER FILED: The Mediation Program of the 9th Circuit Court of Appeals facilitates settlement while appeals are pending. By 07/25/2019, counsel for all parties intending to file briefs in this matter are requested to inform the Circuit Mediator by email of their clients' views on whether the issues on appeal or the underlying dispute might be amenable to settlement presently or in the foreseeable future. This communication will be kept confidential, if requested... This communication should not be filed with the court... The existing briefing schedule remains in effect... [11360452] (VS) [Entered: 07/11/2019 11:07 AM]
July 10, 2019 Filing 4 Filed clerk order (Deputy Clerk: LCC): The courts records reflect that the notice of appeal was filed during the pendency of a timely-filed motion listed in Federal Rule of Appellate Procedure 4(a)(4), and that motion is still pending in the district court. The June 27, 2019 notice of appeal is therefore ineffective until entry of the order disposing of the last such motion outstanding. See Fed. R. App. P. 4(a)(4). Accordingly, proceedings in this court are held in abeyance pending the district courts resolution of the pending June 25, 2019 renewed motion for judgment as a matter of law. See Leader Natl Ins. Co. v. Indus. Indem. Ins. Co., 19 F.3d 444, 445 (9th Cir. 1994). Within 14 days after the district courts ruling on the pending motion, appellant shall file a written notice in this court: (1) informing this court of the district courts ruling; and (2) stating whether appellant intends to prosecute this appeal. To appeal the district courts ruling on the post-judgment motion, appellant must file an amended notice of appeal within the time prescribed by Federal Rule of Appellate Procedure 4. The Clerk shall serve this order on the district court. [11359927] (TSP) [Entered: 07/10/2019 05:09 PM]
July 8, 2019 Filing 3 The Mediation Questionnaire for this case was filed on 07/08/2019. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[11356481][19-55756] (AD) [Entered: 07/08/2019 12:44 PM]
July 8, 2019 Filing 2 Filed (ECF) Appellant Allergan USA, Inc. Mediation Questionnaire. Date of service: 07/08/2019. [11356207] [19-55756] (Akrotirianakis, Joseph) [Entered: 07/08/2019 10:51 AM]
July 1, 2019 Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Mediation Questionnaire due on 07/08/2019. Transcript ordered by 07/29/2019. Transcript due 08/26/2019. Appellant Allergan USA, Inc. opening brief due 10/07/2019. Appellee Imprimis Pharmaceuticals, Inc. answering brief due 11/07/2019. Appellant's optional reply brief is due 21 days after service of the answering brief. [11350771] (RT) [Entered: 07/01/2019 02:42 PM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Allergan USA, Inc. v. Imprimis Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellant: ALLERGAN USA, INC.
Represented By: Joseph Nicholas Akrotirianakis
Represented By: Jeffrey S. Bucholtz Esquire
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellee: IMPRIMIS PHARMACEUTICALS, INC.
Represented By: Keith J. Wesley
Represented By: Carl Alan Roth Esquire
Represented By: David Alexander Grant Esquire
Represented By: Daniel L. Rasmussen Esquire
Represented By: Philip K. Lem Esquire
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?